CSIMarket

Brookline Bancorp inc  (BRKL)
Other Ticker:  
 
    Sector  Financial    Industry S&Ls Savings Banks
   Industry S&Ls Savings Banks
   Sector  Financial
 
Price: $14.1200 $0.24 1.729%
Day's High: $14.135 Week Perf: 2.62 %
Day's Low: $ 13.90 30 Day Perf: 10.23 %
Volume (M): 230 52 Wk High: $ 17.74
Volume (M$): $ 3,252 52 Wk Avg: $15.33
Open: $13.96 52 Wk Low: $12.70



 Market Capitalization (Millions $) 1,093
 Shares Outstanding (Millions) 77
 Employees 675
 Revenues (TTM) (Millions $) 315
 Net Income (TTM) (Millions $) 194
 Cash Flow (TTM) (Millions $) -230
 Capital Exp. (TTM) (Millions $) 4

Brookline Bancorp Inc

Brookline Bancorp, Inc., a Delaware corporation, operates as a multi-bank holding company for Brookline Bank and its subsidiaries, Bank Rhode Island ("BankRI") and its subsidiaries, First Ipswich Bank ("First Ipswich") and its subsidiaries, and Brookline Securities Corp.
Brookline Bank, which includes its wholly-owned subsidiaries, BBS Investment Corp. and Longwood Securities Corp., and its 84.5%-owned subsidiary, Eastern Funding LLC ("Eastern Funding"), operates 25 full-service banking offices in the greater Boston metropolitan area. Brookline Bank was established as a savings bank in 1871 under the name Brookline Savings Bank. The Company was organized in November 1997 for the purpose of acquiring all of the capital stock of Brookline Savings Bank on completion of the reorganization of Brookline Savings Bank from a mutual savings bank into a mutual holding company structure and partial public offering. In 2002, the Company became fully public. In January 2003, Brookline Savings Bank changed its name to Brookline Bank.

As a commercially-focused financial institution with 49 full-service banking offices throughout greater Boston, the north shore of Massachusetts, and Rhode Island, the Company, through Brookline Bank, BankRI and First Ipswich (individually and collectively, the "Banks"), offers a wide range of commercial, business and retail banking services, including a full complement of cash management products, on-line banking services, consumer and residential loans and investment services, designed to meet the financial needs of small- to mid-sized businesses and individuals throughout central New England. Specialty lending activities including equipment financing are focused primarily in the New York and New Jersey metropolitan area.


The Company focuses its business efforts on profitably growing its commercial lending businesses, both organically and through acquisitions. The Company's customer focus, multi-bank structure, and risk management are integral to its organic growth strategy and serve to differentiate the Company from its competitors. As full-service financial institutions, the Banks and their subsidiaries focus on the continued addition of well-qualified customers, the deepening of long-term banking relationships through a full complement of products and excellent customer service, and strong risk management. The Company's multi-bank structure retains the local-bank orientation while relieving local bank management of the responsibility for most back-office functions, which are consolidated at the holding company level. Branding and decision-making, including credit decisions and pricing, remain largely local in order to better meet the needs of bank customers and further motivate the Banks' commercial, business and retail bankers.

The Company, has, from time to time, acquired other business lines or financial institutions that it believes share the Company's relationship and customer service orientations and provide access to complementary markets, customers, products and services. The Company expanded its geographic footprint with the acquisitions of First Ipswich in February 2011 and BankRI in January 2012.


The Company's headquarters and executive management are located at 131 Clarendon Street, Boston, Massachusetts 02116 and its telephone number is 617-425-4600.

Repayment of multi-family and commercial real estate loans is generally dependent on the properties generating sufficient income to cover operating expenses and debt service. Repayment of commercial loans and equipment financing loans and leases generally is dependent on the demand for the borrowers' products or services and the ability of borrowers to compete and operate on a profitable basis. Repayment of residential mortgage loans, home equity loans and indirect automobile loans generally is dependent on the financial well-being of the borrowers and their capacity to service their debt levels. The asset quality of the Company's loan and lease portfolio, therefore, is greatly affected by the economy.



   Company Address: 131 Clarendon Street Boston 2116 MA
   Company Phone Number: 425-4600   Stock Exchange / Ticker: NASDAQ BRKL
   BRKL is expected to report next financial results on November 04, 2022.


Customers Net Income fell by BRKL's Customers Net Profit Margin fell to

-18.73 %

5.71 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
BKU   -5.62%    
CASH   -39.38%    
DCOM   -2.27%    
EVER   -35.4%    
FBC   -13.08%    
UMPQ   -2.46%    
BAC   -21.39%    
C   -13.82%    
COF   -21.98%    
GE   -16.95%    
• View Complete Report
   



Fulcrum Therapeutics Inc.

Losses Widen by Fulcrum Therapeutics Inc in the second quarter of 2022 earnings season report

Fulcrum Therapeutics Inc reported disastrous second quarter of 2022 earnings season, where Sales faded by -57.04% to $1.88 millions and loss per share has widen to $-0.83, from the same quarter a year ago.

Wave Life Sciences Ltd.

Logged a Loss by Wave Life Sciences Ltd in the second quarter of 2022 earnings season announcement

In the second quarter of 2022 earnings season Wave Life Sciences Ltd lost money of $-0.62 per share compared to $-0.78 a year ago and from $-0.62 per share from the previous quarter.

Xometry Inc.

Magnificent 89%, rise in Sales at Xometry Inc in the second quarter of 2022

Strong Sales growth in the second quarter of 2022, by 89% to $95.62 millions helped to cut the loss to $-0.35 per share, from $-1.46 in same quarter a year ago.

Rapt Therapeutics Inc.

The investors are dealing with 1.96%, growth at Rapt Therapeutics Inc in the second quarter of 2022 earnings season

In the second quarter of 2022 earnings season Rapt Therapeutics Inc decreased loss of $-0.62 per share compared to $-0.63 a year ago and improved from $-0.69 per share from the previous quarter.

Fast Radius Inc.

Fast Radius Inc disclosed a similar performance like a year before in the most recent fiscal period

In the most recent fiscal period Fast Radius Inc loss increased of $-0.29 per share compared to $0.00 a year ago and improved from $-0.73 per share from the previous quarter.






 

Brookline Bancorp Inc's Segments
 
 
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TSQ's Profile

Stock Price

TSQ's Financials

Business Description

Fundamentals

Charts & Quotes

TSQ's News

Suppliers

TSQ's Competitors

Customers & Markets

Economic Indicators

TSQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071